86 related articles for article (PubMed ID: 30183581)
1. Prognostic Factors Analysis for Colon Cancer with Lymph Node Negative.
Vîlcea I; Romain B; Rohr S; Burcoş T
Chirurgia (Bucur); 2018; 113(4):503-515. PubMed ID: 30183581
[TBL] [Abstract][Full Text] [Related]
2. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of lymph node ratio and location of nodal involvement in patients with right colon cancer.
Kobayashi H; Enomoto M; Higuchi T; Uetake H; Iida S; Ishikawa T; Ishiguro M; Kato S; Sugihara K
Dig Surg; 2011; 28(3):190-7. PubMed ID: 21555889
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
7. Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer.
Touchefeu Y; Provost-Dewitte M; Lecomte T; Morel A; Valo I; Mosnier JF; Bossard C; Eugène J; Duchalais E; Chetritt J; Guyetant S; Bézieau S; Senellart H; Caulet M; Cauchin E; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1394-1399. PubMed ID: 27606947
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
9. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence.
Burdy G; Panis Y; Alves A; Nemeth J; Lavergne-Slove A; Valleur P
Dis Colon Rectum; 2001 Nov; 44(11):1682-8. PubMed ID: 11711742
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: an international multi-institutional study.
Stojadinovic A; Nissan A; Wainberg Z; Shen P; McCarter M; Protic M; Howard RS; Steele SR; Peoples GE; Bilchik A
Ann Surg Oncol; 2012 Dec; 19(13):4178-85. PubMed ID: 22805869
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
Mayanagi S; Kashiwabara K; Honda M; Oba K; Aoyama T; Kanda M; Maeda H; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T
Dis Colon Rectum; 2018 Jul; 61(7):803-808. PubMed ID: 29561282
[TBL] [Abstract][Full Text] [Related]
13. Perineural invasion and number of retrieved lymph nodes are prognostic factors for T2N0 colon cancer.
Lee SY; Lee J; Park HM; Kim CH; Kim HR
Langenbecks Arch Surg; 2021 Sep; 406(6):1979-1985. PubMed ID: 34129107
[TBL] [Abstract][Full Text] [Related]
14. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of lymph node size in node-positive colon cancer.
Schrembs P; Martin B; Anthuber M; Schenkirsch G; Märkl B
PLoS One; 2018; 13(8):e0201072. PubMed ID: 30096142
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of metastasis and recurrence following curative resection for colonic carcinoma].
Zhao DB; Gao JD; Shan Y; Zhou ZX; Yuan XH; Wu JX; Shao YF
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):291-3. PubMed ID: 16886105
[TBL] [Abstract][Full Text] [Related]
17. The validity of predicting prognosis by the lymph node ratio in node-positive colon cancer.
Sugimoto K; Sakamoto K; Tomiki Y; Goto M; Kojima Y; Komiyama H
Dig Surg; 2013; 30(4-6):368-74. PubMed ID: 24107470
[TBL] [Abstract][Full Text] [Related]
18. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
19. [The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients].
Zheng W; Zhang L; Wu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):679-683. PubMed ID: 30293393
[No Abstract] [Full Text] [Related]
20. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
